Cited by 51Epilepsy research and treatmentPharmacological Effects and Toxicity StudiesDiet and metabolism studies

Human clinical trails in antiepileptogenesis

Open access
Mani, Ram, Pollard, John, Dichter, Marc A.·2011·Neuroscience Letters

Abstract

Blocking the development of epilepsy (epileptogenesis) is a fundamental research area with the potential to provide large benefits to patients by avoiding the medical and social consequences that occur with epilepsy and lifelong therapy. Human clinical trials attempting to prevent epilepsy (antiepileptogenesis) have been few and universally unsuccessful to date. In this article, we review data about possible pathophysiological mechanisms underlying epileptogenesis, discuss potential interventions, and summarize prior antiepileptogenesis trials. Elements of ideal trials designs for successful antiepileptogenic intervention are suggested.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.neulet.2011.03.010

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 45 · Cited by 51

Authors
Mani, R., Pollard, J., & Dichter, M. A.
Affiliations
University of Pennsylvania (US)
Corresponding author
Dichter, Marc A.
Venue
Neuroscience Letters
Publisher
Elsevier BV
Published
2011-06
Volume
497
Issue
3
Pages
251-256
ISSN
0304-3940 (ISSN-L)
OpenAlex
W2119967224
Cited by
51
References
45
Citations by year
2026: 1 · 2023: 1 · 2022: 1 · 2021: 5 · 2020: 4 · 2019: 2 · 2018: 1 · 2017: 6 · 2016: 3 · 2015: 6 · 2014: 6 · 2013: 8 · 2012: 2
FWCI
0.88
Type
journal article
Language
en
Open access
Locations
  • Neuroscience Letters (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health (5r01ns041811-10)
  • National Institute of Neurological Disorders and Stroke (R01 NS-041811)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Epilepsy research and treatment
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmacological Effects and Toxicity Studies
  • Health Sciences › Medicine › Physiology › Diet and metabolism studies
Keywords
antiepileptogenesis, epileptogenesis, epilepsy prevention, clinical trial design
MeSH terms
Anticonvulsants, Brain, Clinical Trials as Topic, Epilepsy, Humans, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review